Crystagen
Glu-Asp-Pro · EDP · Thymus/immune bioregulator
Think of it as a pep talk for your immune system.
Crystagen is like a motivational speech for your immune cells. It's a tiny protein fragment that aims to support your thymus, an organ that plays a big role in immune function. Think of the thymus as a coach for your T-cells, the immune system's frontline fighters. Crystagen tries to give that coach a boost, potentially helping it train those cells better.
Some research, mostly from Russian labs, suggests that it might help your immune system act a bit younger, keeping your defenses sharp by possibly influencing the genes involved in immune responses. However, it's worth noting that these findings are still in early stages and not widely accepted in mainstream science.
Who it's for
- Health enthusiasts curious about immune support
- People interested in anti-aging research
- Biohackers looking for new ways to support their body's defenses
Probably not for you if…
- Folks seeking FDA-approved treatments
- People uncomfortable with experimental compounds
- Those looking for quick, guaranteed results
Editorial summary for research context · Not medical advice
Mechanism of Action
Crystagen is a synthetic tripeptide (Glu-Asp-Pro) designed as a thymus-tissue and immune-system bioregulator. Khavinson-group research proposes that short peptides penetrate the cell membrane, enter the nucleus, and modulate tissue-specific gene expression — in this case in thymic epithelial cells and lymphocyte populations. Positioned as a shorter-sequence analog within the thymic peptide family. Not FDA-approved. Preclinical and limited clinical data from Khavinson group.
Researched Benefits
Thymic gene-expression research
Khavinson-lab studies report modulation of gene expression relevant to thymic epithelial markers and T-cell differentiation pathways.
- [Khavinson & Malinin 2005]
Immune-aging preclinical models
Russian-language studies have examined lymphocyte population shifts and immune markers in aged rodents.
- [Anisimov & Khavinson 2010]
Research Protocols
The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.
Intranasal research protocol
- Dosage
- 100 mcg
- Frequency
- once daily
- Timing
- morning
- Cycle
- 3 weeks
Khavinson-group protocols have typically used 20-30 day cycles, repeated 2x per year.
Reported Side Effects
- No significant adverse events reported in published Khavinson-group studies
- Transient local irritation with intranasal administration
- Long-term human safety data limited
Contraindications
- Pregnancy and lactation (no safety data)
- Active lymphoid malignancy (theoretical concern)
- Autoimmune disease (theoretical concern — consult before use)
- Individual hypersensitivity to peptide components
Stacking Partners
Peptides commonly paired with Crystagen in published research and protocol write-ups.
Vendor Pricing
Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.
Top Videos
Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.
9:15FINAL FANTASY 13-2 FOR BEGINNERS
SuperButterBuns
362.9K views · 9:15 · 10 years ago
7:14Doctor Explains 10 Most Fascinating Peptides
This Is Not Covered - Dr. Ashley Froese
110.5K views · 7:14 · 7 months ago
9:38Insights and Risks with CJC-1295 Ipamorelin
Regan Archibald
94.7K views · 9:38 · 6 months ago
7:05Top 7 Reasons Crystarium is FFXIV's BEST City
Zepla HQ
62.1K views · 7:05 · 6 years ago
11:26FFXIV: The Crystarium Preview
Meoni
15.5K views · 11:26 · 6 years ago
Research Papers
Gerontological aspects of peptide regulation
Khavinson VKh, Malinin VV · Karger · 2005
Peptide bioregulators: the new class of geroprotectors
Anisimov VN, Khavinson VKh · Advances in Gerontology · 2010
